BDTX

NASDAQStock

Black Diamond Therapeutics, Inc.

$2.13-0.01 (-0.23%)

52-Week Range

$1.25
$4.87

Key Stats

Market Cap

121.1M

P/E Ratio

5.90

Dividend Yield

Beta

3.43

Volume

912.2K

Avg Volume

691.6K

Performance

1M

-4.05%

3M

-19.62%

6M

-32.81%

YTD

-14.46%

1Y

+24.56%

3Y

+27.54%

5Y

-91.73%

Price Chart

ETF Exposure

BDTX is held by 22 ETFs

ETFFund NameWeight
STSBiShares Factors US Small Blend Style ETF0.07%
EESWisdomTree U.S. SmallCap Fund0.03%
FESMFIDELITY ENHANCED SMALL CAP ETF0.02%
IWCiShares Micro-Cap ETF0.02%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
IBBQInvesco Nasdaq Biotechnology ETF0.01%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.01%
IBBiShares Biotechnology ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
DFSVDimensional - US Small Cap Value ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
DFATDimensional - US Targeted Value ETF0.00%
VXFVanguard Extended Market ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About BDTX ETF Exposure

Black Diamond Therapeutics, Inc. (BDTX) is held by 22 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.1M, BDTX is a widely held institutional stock. The stock currently trades at $2.13. Investors can gain exposure to BDTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BDTX, sorted by portfolio weight.